{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:35Z","timestamp":1761518915673},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/cmr.0b013e3283021929","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:46:43Z","timestamp":1236260803000},"page":"201-207","source":"Crossref","is-referenced-by-count":14,"title":["Biological value of melanoma inhibitory activity serum concentration in patients with primary skin melanoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Borki","family":"Vu\u010deti\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun\u010dica Andreja","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pero","family":"Hraba\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcis","family":"Hudorovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrvoje","family":"\u010cupi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ljerka","family":"Lukinac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Ledinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aljo\u0161a","family":"Matej\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Lovri\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirta","family":"Zekan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210301","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrc2229","article-title":"Illuminating the metastatic process","volume":"7","author":"Sahai","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R2-6-20210301","first-page":"5358","article-title":"Autocrine tumor cell growth-inhibiting activities from human malignant melanoma","volume":"49","author":"Bogdahn","year":"1989","journal-title":"Cancer Res"},{"key":"R3-6-20210301","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0749.2005.00274.x","article-title":"Melanom inhibitory activity (MIA): an important molecule in melanoma development and progression","volume":"18","author":"Bosserhoff","year":"2005","journal-title":"Pigment Cell Res"},{"key":"R4-6-20210301","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00008390-200108000-00013","article-title":"Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo","volume":"11","author":"Bosserhoff","year":"2001","journal-title":"Melanoma Res"},{"key":"R5-6-20210301","first-page":"3149","article-title":"Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma","volume":"57","author":"Bosserhoff","year":"1997","journal-title":"Cancer Res"},{"key":"R6-6-20210301","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/path.2229","article-title":"Systematic search for the best gene expression markers for melanoma micrometastasis detection","volume":"213","author":"Soikkeli","year":"2007","journal-title":"J Pathol"},{"key":"R7-6-20210301","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00508-006-0603-4","article-title":"The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma","volume":"118","author":"Vuceti\u0107","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"R8-6-20210301","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1365-2168.2002.02236.x","article-title":"Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy","volume":"89","author":"Lens","year":"2002","journal-title":"Br J Surg"},{"key":"R9-6-20210301","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CMR.0b013e3282f62404","article-title":"Routine positron emission tomography and positron emission tomography\/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit","volume":"18","author":"Constantinidou","year":"2008","journal-title":"Melanoma Res"},{"key":"R10-6-20210301","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"R11-6-20210301","first-page":"558","article-title":"Histologic prognostic indicators in cutaneous malignant melanoma","volume":"15","author":"Ronan","year":"1988","journal-title":"Semin Oncol"},{"key":"R12-6-20210301","first-page":"353","article-title":"Cuatenous melanoma: clinical managment and treatment results worldwide","author":"Soong","year":"1985"},{"key":"R13-6-20210301","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11912-001-0086-4","article-title":"Review of the 2001 AJCC staging system for cutaneous malignant melanoma","volume":"3","author":"Schuchter","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"R14-6-20210301","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaad.2006.12.028","article-title":"Association between the anatomic distribution of melanoma and sex","volume":"56","author":"Clark","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R15-6-20210301","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"R16-6-20210301","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00000478-199907000-00011","article-title":"Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin","volume":"23","author":"Blaheta","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R17-6-20210301","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<318::AID-IJC3>3.0.CO;2-Y","article-title":"Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry","volume":"79","author":"Blaheta","year":"1998","journal-title":"Int J Cancer"},{"key":"R18-6-20210301","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0039-6109(05)70255-3","article-title":"Melanoma metastases through the lymphatic system","volume":"80","author":"Cochran","year":"2000","journal-title":"Surg Clin North Am"},{"key":"R19-6-20210301","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00008390-199212000-00006","article-title":"Purification and analysis of growth regulating protein secreted by a human melanoma cell line","volume":"2","author":"Apfel","year":"1993","journal-title":"Melanoma Res"},{"key":"R20-6-20210301","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000030147","article-title":"Comparison of two prognostic markers for malignant melanoma: MIA and S 100 beta","volume":"22","author":"Juergensen","year":"2001","journal-title":"Tumour Biol"},{"key":"R21-6-20210301","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1200\/JCO.1999.17.6.1891","article-title":"S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma","volume":"17","author":"Deichmann","year":"1999","journal-title":"J Clin Oncol"},{"key":"R22-6-20210301","first-page":"2203","article-title":"Comparison of S100 protein and MIA protein as serum marker for malignant melanoma","volume":"20","author":"Djukanovic","year":"2000","journal-title":"Anticancer Res"},{"key":"R23-6-20210301","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0151-9638(07)89264-7","article-title":"Protein S100 beta and melanoma inhibitory activity (MIA): a prospective study of their clinical value for the early detection of metastasis in malignant melanoma","volume":"134","author":"Loppin","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"R24-6-20210301","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/07357900701208634","article-title":"A comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients","volume":"25","author":"Faries","year":"2007","journal-title":"Cancer Invest"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008390-200806000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:25:59Z","timestamp":1710127559000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-200806000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e3283021929","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}